{"disease":{"id":"potentially-resectable-locally-advanced-malignant-tumors-of-biliary-system","name":"potentially resectable locally advanced malignant tumors of biliary system"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05036798","title":"Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System.","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}